McGuire Investment Group LLC Raises Stock Position in ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

McGuire Investment Group LLC grew its stake in shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) by 28.1% during the 4th quarter, HoldingsChannel.com reports. The fund owned 10,310 shares of the company’s stock after purchasing an additional 2,260 shares during the quarter. McGuire Investment Group LLC’s holdings in ALPS Medical Breakthroughs ETF were worth $341,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of SBIO. Jane Street Group LLC acquired a new position in shares of ALPS Medical Breakthroughs ETF during the 3rd quarter worth approximately $366,000. Griffin Asset Management Inc. lifted its stake in ALPS Medical Breakthroughs ETF by 31.2% during the third quarter. Griffin Asset Management Inc. now owns 30,135 shares of the company’s stock worth $1,125,000 after purchasing an additional 7,170 shares in the last quarter. Finally, International Assets Investment Management LLC purchased a new position in ALPS Medical Breakthroughs ETF during the 3rd quarter valued at about $61,430,000.

ALPS Medical Breakthroughs ETF Trading Down 0.6 %

Shares of NYSEARCA SBIO opened at $32.33 on Friday. The business’s fifty day simple moving average is $34.89 and its 200-day simple moving average is $36.60. ALPS Medical Breakthroughs ETF has a 12-month low of $30.07 and a 12-month high of $42.73.

ALPS Medical Breakthroughs ETF Profile

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.